In conclusion, our systematic review and meta-analysis demonstrates that FADD upregulation, especially with regard to immunohistochemical protein overexpression, behaves as a powerful prognostic predictor in HNSCC as a consequence of its association with higher clinical stage and N positive status. This evidence concerns the gene FADD and head and neck squamous cell carcinoma.